Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sherman

Showing results (751-760 of 1,108) with videos related to

Pageof 111
Sort By:
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 7, 2019
Enhanced Subchondroplasty Treatment for Post-Traumatic Cartilage and Subchondral Bone Marrow Lesions in a Canine ModelHarvey A Oliver, Chantelle C Bozynski, Cristi R Cook, et al.
Journal of Clinical Pharmacology|August 14, 2013
Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal womenMatthew L Sherman, Niels G Borgstein, Louisa Mook, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 11, 2012
Defining quality for distal pancreatectomy: does the laparoscopic approach protect patients from poor quality outcomes?Marshall S Baker, Karen L Sherman, Susan Stocker, et al.
Journal of the National Cancer Institute|September 7, 1988
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic studyD R Spriggs, M L Sherman, H Michie, et al.
Journal of the American College of Cardiology|June 1, 1986
Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysisP R Eisenberg, L Sherman, M Rich, et al.
Journal of Neurodevelopmental Disorders|April 8, 2021
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language samplingAngela John Thurman, Jamie O Edgin, Stephanie L Sherman, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 1, 1993
Structural abnormalities associated with congenital megacolon in transgenic mice that overexpress the Hoxa-4 geneV M Tennyson, M D Gershon, D L Sherman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 4, 2020
Cell-Penetrating Anti-Protein Kinase C Theta Antibodies Act Intracellularly to Generate Stable, Highly Suppressive Regulatory T CellsE Ilker Ozay, Sudarvili Shanthalingam, Heather L Sherman, et al.
Oncogene|December 12, 1997
Interdomain binding mediates tumor growth suppression by the NF2 gene productL Sherman, H M Xu, R T Geist, et al.
Cancer|May 31, 2019
GIScience and cancer: State of the art and trends for cancer surveillance and epidemiologyLiora Sahar, Stephanie L Foster, Recinda L Sherman, et al.
Pageof 111

Showing results (751-760 of 1,108) with videos related to

Sort By:
Pageof 111
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 7, 2019
Enhanced Subchondroplasty Treatment for Post-Traumatic Cartilage and Subchondral Bone Marrow Lesions in a Canine ModelHarvey A Oliver, Chantelle C Bozynski, Cristi R Cook, et al.
Journal of Clinical Pharmacology|August 14, 2013
Multiple-dose, safety, pharmacokinetic, and pharmacodynamic study of sotatercept (ActRIIA-IgG1), a novel erythropoietic agent, in healthy postmenopausal womenMatthew L Sherman, Niels G Borgstein, Louisa Mook, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 11, 2012
Defining quality for distal pancreatectomy: does the laparoscopic approach protect patients from poor quality outcomes?Marshall S Baker, Karen L Sherman, Susan Stocker, et al.
Journal of the National Cancer Institute|September 7, 1988
Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacologic studyD R Spriggs, M L Sherman, H Michie, et al.
Journal of the American College of Cardiology|June 1, 1986
Importance of continued activation of thrombin reflected by fibrinopeptide A to the efficacy of thrombolysisP R Eisenberg, L Sherman, M Rich, et al.
Journal of Neurodevelopmental Disorders|April 8, 2021
Spoken language outcome measures for treatment studies in Down syndrome: feasibility, practice effects, test-retest reliability, and construct validity of variables generated from expressive language samplingAngela John Thurman, Jamie O Edgin, Stephanie L Sherman, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|September 1, 1993
Structural abnormalities associated with congenital megacolon in transgenic mice that overexpress the Hoxa-4 geneV M Tennyson, M D Gershon, D L Sherman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 4, 2020
Cell-Penetrating Anti-Protein Kinase C Theta Antibodies Act Intracellularly to Generate Stable, Highly Suppressive Regulatory T CellsE Ilker Ozay, Sudarvili Shanthalingam, Heather L Sherman, et al.
Oncogene|December 12, 1997
Interdomain binding mediates tumor growth suppression by the NF2 gene productL Sherman, H M Xu, R T Geist, et al.
Cancer|May 31, 2019
GIScience and cancer: State of the art and trends for cancer surveillance and epidemiologyLiora Sahar, Stephanie L Foster, Recinda L Sherman, et al.
Pageof 111